David Daly
CIK 1320267 · President and Chief Operating · last filed 2022-06-14
David Daly is a President and Chief Operating who has filed 38 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing, for NEO, was dated Jun 14, 2022. Across all open-market trades the lifetime net is −$2.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $191.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$191.5K
4
38
-$2.66M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NEO | Director | 17,179 | $11.15 | $191.5K | $0 | 2 | 2022-06-14 |
| Singular Genomics Systems, Inc. (OMIC) Delisted | President and Chief Operating | — | $20.01 | — | $0 | 1 | 2022-03-08 |
| Foundation Medicine, Inc. (FMI) Delisted | Chief Commercial Officer | 116,261 | — | — | -$2.51M | 18 | 2017-08-10 |
| CLARIENT, INC (CLRT) Delisted | Chief Commercial Officer | 0 | — | — | -$143.8K | 17 | 2010-12-23 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-14 | NEO | Grant (A) | +15,556 | $0 | EDGAR |
| 2022-03-08 | Singular Genomics Systems, Inc. (OMIC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-12 | NEO | Grant (A) | +1,623 | $0 | EDGAR |
| 2017-08-10 | Foundation Medicine, Inc. (FMI) Delisted | Mixed | — | -$809.0K | EDGAR |
| 2017-07-07 | Foundation Medicine, Inc. (FMI) Delisted | Sell (S) | −6,316 | -$245.3K | EDGAR |
| 2017-06-05 | Foundation Medicine, Inc. (FMI) Delisted | Sell (S) | −555 | -$21.3K | EDGAR |
| 2017-05-03 | Foundation Medicine, Inc. (FMI) Delisted | Grant (A) | +24,550 | $878.9K | EDGAR |
| 2017-04-05 | Foundation Medicine, Inc. (FMI) Delisted | Sell (S) | −2,070 | -$66.2K | EDGAR |
| 2017-03-03 | Foundation Medicine, Inc. (FMI) Delisted | Sell (S) | −541 | -$13.6K | EDGAR |
| 2017-01-05 | Foundation Medicine, Inc. (FMI) Delisted | Sell (S) | −5,097 | -$91.3K | EDGAR |